David Sinclair, a professor at Harvard Medical School, has said that he thinks the first person who will live to the age of 150 is already alive today. During a panel discussion about longevity at the TIME100 Health Leadership Forum in New York City on Sept. 10, TIME executive editor Nikhil Kumar asked Sinclair what motivated him to say that. Garrison’s longevity work focuses largely on women’s health, in particular on ovaries—something she said affects not just women, but everyone, because “understanding the differences between male bodies and female bodies gives us levers with which to develop medicines.” “When we miss female physiology, we’ve essentially left out half of the picture,” she said.
For example, she said, female bodies tend to be better at fighting viruses than male bodies. Researchers don’t fully understand why, but if they were able to understand those differences, it could help better equip the medical community to treat everyone depending on their needs, Garrison argued. When Kumar asked her how far along the medical field is in understanding these differences, Garrison replied, “We’re pretty far behind, as it turns out.” But, she continued, “Everyone understands that there’s a challenge here that we’ve got a data gap, that we’ve got this systemic bias about our research, that we’re essentially, I think, generations behind.” “It’s not years.
It’s generations behind in terms of the data,” she said. But “the entire healthcare system is not designed to solve that problem; it’s designed to solve that real sick person who is dying.” Since then, Jia has broadened Musely’s scope to include resources and treatments for proactive health and longevity. Kumar went on to ask the panelists what they think about the recent “explosion in testing” in the longevity space—how people are getting all kinds of tests and scans to, they claim, optimize living longer and better.
Garrison said that, where there is evidence for the test, it’s a great option. But that is not always the case. And part of the problem is that it’s very hard as a consumer, as someone who’s not a scientist or a doctor, to really make the call between, ‘Is this real or not?’” Sinclair expressed concerns that what people used to consider to be “fringe” behaviors, such as injecting oneself with peptides or taking drugs that have not yet been proven to be effective in humans, is becoming more common.
Extract — continue reading at the source.
